CCA
PRAH

Catalyst Capital Advisors’s PRA Health Sciences, Inc. PRAH Stock Holding History

Catalyst Capital Advisors’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-86
Closed -$8K – 498
2018
Q4 		$8K Sell
86
-23
-21% -$2.33K ﹤0.01% 319
2018
Q3 		$12K Buy
109
+40
+58% +$4.17K ﹤0.01% 326
2018
Q2 		$6K Buy
69
+15
+28% +$1.29K ﹤0.01% 430
2018
Q1 		$4K Buy
+54
New +$4.8K ﹤0.01% 437

Other funds holding PRAH

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Catalyst Capital Advisors's PRAH Position: Q1 2019 in Review

Catalyst Capital Advisors sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2019, closing a stake of 86 shares — an estimated $8K sold.

Catalyst Capital Advisors first reported a position in PRAH in Q1 2018 and held it in 4 quarters. The position peaked at $12K in Q3 2018. 354 funds tracked by Wall St. Rank hold PRAH as of Q1 2019.

  • Catalyst Capital Advisors reported no remaining PRA Health Sciences, Inc. position as of Q1 2019 after selling out during the quarter.
  • Catalyst Capital Advisors sold 86 PRA Health Sciences, Inc. shares in Q1 2019, an estimated $8K.
  • Catalyst Capital Advisors first reported a position in PRA Health Sciences, Inc. in Q1 2018 and held it in 4 quarters.
  • Catalyst Capital Advisors's PRA Health Sciences, Inc. position peaked at $12K in Q3 2018.
  • 354 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2019.

Based on Catalyst Capital Advisors's 13F filing for Q1 2019, filed 8 May 2019.